Jared Gollob

CIK 1821198 · Chief Medical Officer · last filed 2026-03-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$14.00M

Companies

1

Total Filings

28

Lifetime Open-Market Net

-$20.60M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KYMR Chief Medical Officer 117,581 $119.05 $14.00M -$20.60M 18 2026-03-04

Recent Filings · Page 2 of 3

28 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-07-16 KYMR Notice (144) −23,145 -$1.04M EDGAR
2024-07-16 KYMR Mixed -$1.72M EDGAR
2024-07-15 KYMR Notice (144) −16,455 -$696.0K EDGAR
2024-03-04 KYMR Mixed +21,031 -$140.0K EDGAR
2024-03-04 KYMR Notice (144) −3,344 -$145.5K EDGAR
2024-02-29 KYMR Mixed -$17.2K EDGAR
2024-02-27 KYMR Notice (144) −400 -$17.4K EDGAR
2024-02-09 KYMR Notice (144) −46,137 -$1.57M EDGAR
2024-02-09 KYMR Mixed -$1.54M EDGAR
2023-03-03 KYMR Mixed +17,452 -$40.2K EDGAR
Showing 1120 of 28
Page 2 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.